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The induction of immunological reactivity to type II collagen, a major component 
of cartilage, has recently been used to establish an experimental model of arthritis in 
the rat  (1).  Trentham and colleagues (1)  have shown that the intradermal  injection 
of collagen  in  Freund's  complete  or  incomplete  adjuvant  elicits  an  arthritogenic 
reaction, specifically with native type II collagen. Arthritis occurs in 40% of the rats 
injected,  and  this arthritis  could be passively transferred by the  transplantation  of 
immunocompetent  cells  (2).  There  was  also  a  correlation  between  the  humoral 
response to type II collagen and the occurrence of arthritis  (3). 
The relationship between the collagen arthritis model in the rat  and rheumatoid 
arthritis (RA) 1 is unclear. The histology demonstrated in the experimental model (I) 
was very similar to that  seen in  RA, and x-rays taken of the joints of affected rats 
show erosive damage as seen in human rheumatoid disease (4). Autoimmunity to type 
II collagen has been observed in RA, with circulating antibodies in the majority of 
patients  (5,  6)  and  an  abnormal  cellular  response assessed  by leukocyte inhibition 
factor production (7). It is conceivable that an abnormal immune response to type II 
collagen could be relevant in the joint inflammation found in RA. 
It has been shown that antigens of the major histocompatibility complex (MHC) 
may be related  to  both  the  susceptibility  to  disease  (8,  9)  and  the  control  of the 
immune response  (10,  11).  Because human lymphocyte antigens  influence suscepti- 
bility to various human arthritides, it is particularly relevant to examine the genetic 
control  of the  immune response to  type II collagen  in  the experimental  model  of 
arthritis. However, the MHC of rats is not as well documented as that of mice. Recent 
evidence has shown that type II collagen arthritis may be induced in mice (12). 
This paper reports on the incidence of type II collagen arthritis in various strains 
of mice and maps the susceptibility to the disease within  the I region of the MHC. 
The humoral immune response to type II collagen was also investigated, and strains 
susceptible to type II collagen arthritis correlate well with high antibody responders 
to the same antigen. 
* Supported by grant CA-24473 from the  National Cancer Institute and  a grant from the  Mayo 
Foundation. 
1  Abbreviations used in this paper: BSA, bovine serum albumin; CFA, complete Freund's adjuvant; MHC, 
major histocompatibility  complex; PBS, phosphate-buffered  saline; RA, rheumatoid arthritis. 
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Materials  and  Methods 
Mice.  Mice were bred and maintained in the Mouse Immunogeneties Colony, Mayo Clinic, 
with the exception of DBA/IJ mice, which were obtained from The Jackson Laboratory, Bar 
Harbor, Maine. 
Collagen.  Native type II collagen was purified from  lathyritic chick preparations by the 
method of Cremer et al. (13). 
Induction of Arthritis.  Native type II collagen was solubilized in 0.1  M  acetic acid at  1 mg/ 
ml, and emulsified in complete Freund's adjuvant (CFA). Mice were primed with  100/zg of 
type II collagen in CFA injected intradermally at four to six sites on the back. Control mice 
were primed with acetic acid emulsified in CFA. Mice were challenged after 21 d with 100 btg 
of type II collagen in  100 #1 acetic acid, injected intraperitoneally. Control mice received 100 
#1 of 0.1 M  acetic acid alone, intraperitoneally. 
Assessment of Arthritis 
MEASUREMENT OF JOINT THICKNESS.  Mouse joints were measured using a  constant tension 
caliper (Schelhaster, Syitem, Krfplin, Germany). All mice were measured before the start of 
the experiment to obtain base-line readings at three joints on the hind limb (paw thickness, 
ankle width, and knee width) and two joints on the fore limb (paw thickness and elbow width). 
All mice of a strain with any visual appearance of arthritis were measured daily to observe 
the progress of  joint swelling during the course of the disease, and to measure the variation in 
measurement of normal joints. 
CLINICAL EVALUATION.  All mice were examined daily for the initial visual appearance of 
arthritis:  redness  and  swelling of a  fore or hind  paw.  Dates  of onset  of the  disease after 
immunization were recorded for individual mice. 
An arthritic index of the disease was developed, based upon the visual appearance of a limb 
and the caliper measurements. Limbs were graded 0-3, representing increased joint swelling, 
erythema, and visible  joint distortion. Changes in the number of affected limbs and the arthritis 
index for each limb were recorded on a daily basis. 
HISTOLOGICAL EVALUATION.  Mice were killed at various intervals during the experiment. 
Histological sections were prepared by the Pathology Department, Mayo Clinic. Limbs were 
dissected out for histology, and the clinical joint assessment was coded for blind observation. 
Joints were decalcified in Surgipath Decal (Medical Industries, Inc., Northbrook, Ill.) for 3-4 
d and embedded in paraffin blocks. Sections of 6-pm thickness were cut along a  longitudinal 
axis at a number of varying depths for each joint, mounted, and stained with hematoxylin and 
eosin before grading. The histological grading system was based upon  (a)  inflammation (b) 
erosion and pannus formation, and (c) ankylosis. 
Antibody Quantitation.  Mice  were  bled  for  sera  on  at  least  three  occasions  during  the 
experiments: (a) day 7, primary response; (b) day 28, secondary response; and (c) bleed out. 
Sera were tested for antibodies to type II collagen using a  solid-phase radioimmunoassay, 
developed from the method of Clague et al. (14). 
Polystyrene tubes (LP3 Luckhams, Sussex, England) were coated with type II collagen by 
the addition of 3/,tg of collagen solubilized in 20 ~1 of 0.1 M  acetic acid, followed by 500 #1 of 
phosphate-buffered saline (PBS). After overnight incubation at 4°C and washing three times 
with 1 ml PBS, the remaining protein binding sites were blocked by the addition of 500 pl of 
0.1% bovine serum albumin (BSA) in PBS for 4 h at room temperature. The tubes were washed 
three times with  1 ml PBS before the addition of 10/~1 of mouse test sera and 500 ~1 of 0.1% 
BSA/PBS. The preparation was incubated overnight at 4°C, then washed three times with 1 
ml PBS. Bound IgG was measured by the addition of iodinated (1~I) Staphylococcus protein A, 
0.025 pg in 500/xl BSA/PBS for 45 rain at 4°C. The tubes were washed three times with 1 ml 
PBS and bound 12hi-Staphylococcus protein A measured in a  gamma counter (Beckman Instru- 
ments, Inc., Fullerton, Calif.). 
The quantity of IgG anti-type II collagen antibody was expressed as micrograms per milliliter 
by comparison against a purified guinea pig anticollagen IgG control. 
Results 
Characteristics  of Type H  Collagen-induced Arthritis.  The intradermal injection of 100 
pg of type II collagen in CFA, followed by a  further  100 #g injected intraperitoneally 
after 21  d, induced an arthritis in a  variable percentage of mice of susceptible strains. 690  TYPE  II COLLAGEN-INDUCED ARTHRITIS IN  MICE 
Fro.  1.  The appearance of a normal mouse hindlimb (A) in contrast to the appearance of mouse 
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The initial  signs of collagen arthritis  were swelling and erythema  in one or more 
paws.  The disease would progress  at  a  variable  rate,  and other limbs could become 
involved  at  later  intervals.  Increases  in  paw  thickness  (arthritis/preonset)  were  re- 
corded from 1.16-2.25, with a  mean of 1.78 at peak disease. The variation in clinical 
limb score from 0-3 is exemplified by Fig.  1 A  and B. The number of limbs involved 
and the stage of the disease allowed a clinical score of 0-12. 
The date of onset of collagen arthritis  was extremely variable:  from  19 d  after the 
initial injection  (preboost)  to  112 d, with a  mean of 46.8 d. The date of peak disease 
was also variable, with a  mean of 10.8 d  after onset. 
No  involvement  of vertebral  joints  or  other  extraarticular  manifestations  was 
observed in type II collagen arthritis in mice. No control mice receiving adjuvant and 
acetic acid alone were observed to suffer any form of arthritis. 
Histological Appearance of Collagen Arthritis.  Results  of the  histological  section  are 
shown  in  Figs.  2  and  3.  Fig.  2  shows  a  section  through  a  mouse  foot.  The  section 
reveals  the  tarsal  area  with  the  articular  surface  of the  tarsal  bones  covered  with 
hyaline cartilage that is of uniform thickness and has a  smooth surface. The synovial 
lining is barely perceptible and is one to two cell layers thick. Soft tissues surrounding 
the joint are normal. 
Fig.  3  shows  the  grading  system  used  in  this  study.  In  some  sections  the  only 
abnormality seen was mononuclear cell proliferation  in the superficial  layers of the 
synovium-stage I  (Fig. 3 A). This could be seen to progress to pannus formation with 
damage  to the superficial  layers of the cartilage--stage  2  (Fig.  3 B).  Fig.  3 C  shows 
Fro. 2.  Cross-section of the foot from a normal mouse. Hemotoxylin and erosion X 64. Arrows 
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Fio.  3.  Sections  through  various joints  of mice  with  collagen  type  II-induced  arthritis.  (A) 
Mononuclear cell infiltrate in synovial lining X  100 (arrows). (B) Pannus formation with superficial 
cartilage damage ×  100 (arrows). (C) Subchondral bone erosion X 64 (arrows). (D) Complete joint 
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stage  III of the inflammatory process with  development  of bone erosions.  Stage IV 
(Fig.  3 D)  demonstrated  severe osteolysis, with complete disorganization of the joint 
space and replacement with mononuclear cells, destruction of cartilage, subchrondral 
bone, and in some areas, development of fibrous or bony ankylosis. 
In each animal  the range of involvement varied from normal joints to stage I-IV 
destruction. There was good correlation between the clinical score and the histological 
score  (Table  I)  except  for B10.S  animals  that  clinically  were  normal  but  revealed 
some mononuclear cell hyperreactivity in the synovial lining.  There was no pannus 
identified and no cartilage or bone destruction noted. 
Strain Differences in Susceptibility  to Type H  Collagen Arthritis.  Two categories of mice 
were  studied  to  investigate  genetic  differences  in  susceptibility  to  type  II collagen 
arthritis  (Table II): first,  inbred  mice of known H-2 type with  varying background 
genes,  and  second,  inbred  mice  of varying  H-2  haplotypes  congeneic  to  the  B10 
background. 
Only mice bearing the H-2  q haplotype (B10.Q, B10.G, and DBA/IJ) were suseep- 
TABLE  I 
Histological Appearance of Mouse  Joint Sections 
Histological grade (range) 
CBA/N  0 
DBA/IJ  1-4 
B10.Q  1-3 
B10.F  0 
B 10.WB  0 
B10.S  0-1 
B 10.AQR  0 
B 10.T(6R)  1-4 
B10.BYR  0 
B 10.DA  1-4 
BI0.AKM  0 
TABLE II 
Incidence of Type H Collagen-induced Arthritis in Independent Haplotype Mice 
Strain  H-2 haplotype  Arthritis incidence 
DBA/IJ  q  3/7 
CBA/N  k  0/6 
B10  b  0/5 
B 10.D2  d  0/8 
B 10.MB  f  0/6 
BIO.WB  j  0/12 
B10.K  k  0/6 
B 10.BR  k  0/12 
B10.F  p  0/8 
B10.G  q  5/12 
B10.Q  q  15/20 
B10.RIII  r  0/12 
B10.S  s  0/18 
B10.PL  u  0/5 
B10.SM  v  0/10 P.  H.  WOOLEY, H.  S.  LUTHRA, J.  M.  STUART,  AND (3.  S.  DAVID 
TABLE III 
Incidence of Type H Collagen-induced Arthritis in Recombinant Haplotype 
Mice 
Strain  Type  Arthritis incidence 
B  10.AQR  KqIkD  d  0/10 
B 10.T(6R)  KqlqD  d  10/20 
B  10.BYR  KqIkD  b  0/12 
B 10.DA  KqIqD  s  15/26 
B 10.AKM  KkIkDq  0/7 
B 10.MBR  KbIkD  q  0/6 
TABLE IV 
Incidence of Type H Collagen-induced Arthritis in 
(Resistant X  Susceptible)F1 Mice 
Arthritis 
Strain  H-2 haplotype  incidence 
B10.Q  q  15/20 
B  10.M  f  0/6 
B 10.A(4R)  h4  0/5 
(B10.Q × BI0.M)F1  q/f  3/4 
(B10.Q × B10.A(4R))F~  h4/q  1/6 
TABLE V 
Strain Differences Observed in Type II Collagen Arthritis-susceptible  Mice 
695 
Strain  Incidence 
Mean 
Limbs  Clinical 
Onset  involved  score  Collagen AB 
d 
B10.Q  15/20 (75%)  47.1  2.33  5.54  557 + 84 
B10.G  5/12 (41.7%)  49.3  1.20  2.00  337 ±  136 
B10.DA  15/26 (57.7%)  45.0  2.73  6.60  404 ± 77 
B10.T(6R)  10/20 (50%)  44.2  1.90  3.80  368 ± 54 
B10(Q× M)FI  3/4  (75%)  46.0  2.66  6.33  634 ±  154 
BI0(Q× A(4R))F1  1/6  (16.7%)  51  2  5  373 
DBA/IJ  3/7  (42.9%)  57.7  2.33  5.53  426 ±  116 
tible to collagen arthritis. No sex differences were observed with respect to disease in 
the B10.Q or B10.G mice, with only male DBA/IJ mice being investigated. 
Gene Mapping of Susceptibility of Type II Collagen Arthritis.  Recombinants within the 
H-2 complex (Table III) were used to map susceptibility to collagen arthritis to the I q 
region. Strains bearing K q alone (B 10.AQR, B 10.BYR) were resistant, whereas strains 
with KqI  q (B10.DA, B10.T[6R])  were susceptible to collagen arthritis. The involve- 
ment of genes to the right of the I region was eliminated by the resistance of B 10.AKM 
and B10.MBR, which bear D q. The susceptibility genes could not be mapped to a 
specific  I  subregion  because  intra-I  region  recombinants  involving H-2  q  are  not 
available. 
Type  H  Collagen Arthritis  in  the  (Resistant  ×  Susceptible)F1 Animals.  Two  crosses 
involving B10.Q and  a  resistant  strain  were  investigated,  (B10.Q  ×  B10.M)  and 696  TYPE  II  COLLAGEN-INDUCED  ARTHRITIS  IN  MICE 
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(B10.Q ×  B10.A[4R])  (Table IV). The susceptibility to collagen arthritis was domi- 
nant in the F1 animals, with a  similar incidence of arthritis as that of the parental 
(B 10.Q) strain observed in the (B 10.Q ×  B 10.M)Fz, but a low incidence of the disease 
in the (B10.Q ×  B10.A[4R])Fx (Table IV). Further crosses are under investigation to 
study the incidence of arthritis in F1, F2, and backcross mice. 
Strain Differences in  the  Incidence and Appearance of Type H  Collagen Arthritis.  The 
incidence, onset, and  gradation  of collagen arthritis  for each susceptible strain  are 
summarized in Table V. The incidence of arthritis in B 10.Q mice was 75%. 
No significant differences were seen in the time of disease onset between strains. 
However, comparison of  the maximum clinical score observed between strains revealed 
a significant variation in disease severity between B 10.Q and B 10.G, both strains of 
which  carry  the  H-2  q haplotype.  Table  V  shows  B10.G  to  have  a  lower  disease 
incidence, fewer involved limbs, and a lower clinical score than B10.Q. Independent 
t  tests showed significant differences in the comparison of arthritis mice of the two 
strains  (P <  0.05), and when the strains were compared overall (which tests for the 
low incidence in B10.G), the difference was highly significant (P <  0.01). A similar 
difference was  seen  in  the comparison of B10.G with  B10.DA;  however, no other 
differences between strains were observed. 
The Genetic Control of Anti-Type H Collagen Antibody.  The antibody response to type 
II collagen in all independent haplotypes investigated is shown in Fig. 4. Strains were 
classified as low responders (0-100 ~g/ml), intermediate responders (100-300 ~tg/ml), 
and  high  responders  300+  /Lg/ml).  Mouse  strains  susceptible  to  type  II  collagen 
arthritis (B 10.O~ B 10.G, DBA/IJ, B10.T[6R], B 10.DA, and F1 crosses of B 10.Q) were 
all  high  responders to type II collagen. High antibody responses were also seen in 
B10, B10.D2,  and  B10.S  mice, however,  there was  a  significant  association  (X  2 ~- 
10.65, P <  0.005) between high anti-type II collagen antibody levels and susceptibility 
to collagen arthritis. Antibody titers in Fx animals were similar to the higher responder 
(B 10.Q) parental titer. Low antibody responses were associated with the H-2  j'p'q'k'u'v'k 
haplotypes, intermediate responses were associated with the H-2" haplotype, and high 
responses were associated with the H-2  q's'd'b haplotypes. Intermediate responses were 
seen  in  the  recombinant  strains  B10.AQR,  B10.BYR,  B10.MBR,  B10.AKM,  and 
B10.A(4R),  suggesting  possible  influence  of  H-2D  end  in  anti-type  II  collagen 
antibody response. Anticollagen antibody titers in control animals were found to be 
0-12/xg/ml. 
Relationship between Anti-Type H Collagen Antibody and Type II Collagen Arthritis.  The 
antibody levels found in arthritic mice (Table V) are not significantly different from 
the mean antibody levels in comparable strains (Fig. 4). 
Discussion 
These data indicate that the intradermal injection of native chick type II collagen 
in CFA may induce arthritis in ~50% of mice of susceptible strains. 
The arthritis was characterized by initial redness and swelling of one or more limbs, 
which resulted in increases of paw thickness of 30-120%. Later clinical characteristics 
of the disease included gross joint deformation and total loss of joint mobility. The 
time-course of the disease was extremely variable, with disease onset varying from 19- 
112 d after the primary injection. Also, the involvement of other limbs after the onset 
was  unpredictable.  Mice  with  single  limb  involvement  appeared  most  likely  to 698  TYPE II COLLAGEN-INDUCED ARTHRITIS IN MICE 
experience disease recession; however, no spontaneous exacerbations were observed in 
any animal after recession. The examination of sections of affected joints revealed a 
good  correlation  between  the  clinical  score  and  the  histological  score  in  type  II 
collagen arthritis. No clinical or histological evidence of arthritis was seen in control 
animals receiving CFA and acetic acid alone. 
The  clinical  and  histological  appearance  of collagen  arthritis  in  the  mouse  is 
essentially similar to that described in the rat (1), however, the median onset date was 
later  in  mice,  and  additional  limbs  showed  involvement  at  periods  >48  h.  Peak 
severity of the disease was also attained after a longer period in the mouse. 
These results are in agreement with the findings of Courtenay et al. (12), who also 
demonstrated  a  further  increase  in  the  disease  time-course  by  using  incomplete 
adjuvant. 
Because the induction of arthritis is dependent upon the intradermal injection of 
type II collagen in adjuvant,  it is conceivable that  the delayed development of the 
disease in mice may be related to the lack of arthritogenic activity of adjuvant  in 
mice. Also, because CFA is nonarthritogenic in mice, it is apparent that the type II 
collagen presented in this manner is responsible for the disease. 
The initial  experiments of this study indicated that  only mice bearing the H-2  q 
haplotype were susceptible to type II collagen arthritis. The influence of non-MHC 
genes upon susceptibility to type II collagen arthritis is unclear because DBA/IJ mice 
showed a  similar  incidence and  course of the  disease as  did  B10.Q. mice, whereas 
B10.G mice, with similar background and MHC genes as Bl0.Qmice, showed a lower 
incidence and  less  severe course of collagen  arthritis.  This  may  indicate  that  the 
susceptibility gene of collagen arthritis may be linked to the MHC genes responsible 
for the expression of H-2  q antigens, and the different origin of MHC regions in B 10.Q. 
and B 10.G may have influenced the action of the disease susceptibility gene to some 
extent. Investigation of (B10.G ×  B10.Q)F1 animals is at present underway to study 
this phenomena. The use of recombinant congenic mouse strains further mapped the 
susceptibility to be controlled within the I q region. This genetic specificity of collagen 
arthritis was not observed by Courtenay et al.  (12), however, this may indicate that 
the response to bovine collagen may differ in genetic control to the response to chick 
collagen. The humoral (15, 16) and cellular (17) immune response to bovine collagens 
is  under the control of H-2-1inked Ir genes.  We can postulate that  Ia  antigens  on 
macrophages of I q strains can effectively present type II chick collagen to trigger anti- 
self response. On the other hand, Ia  d'b'~ may be presenting the chick type II collagen 
in a manner in which only heterologous antibodies are generated. 
It has also been proposed that the native type II collagen molecule contains at least 
two antigenic determinants (18). It is conceivable that immunization with extracted 
type II collagen could elicit an immune response against collagen determinants that 
are hidden  within the  cartilage of the joint.  Such  an  immune  response should  be 
detectable by the in vitro assay against the immunizing agent, extracted collagen, but 
the response should not be pathogenic due to the inaccessibility of the determinant in 
vivo. However, should the response be directed against  collagen determinants that 
are expressed on joint cartilage, it is possible that autoimmune damage could result. 
Thus, the immune response seen in I q haplotype mice may indicate a specific response 
against type II collagen antigenic determinants expressed within the joint. Alterna- 
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II collagen cross-reacts with autologous mouse collagen and results in an autoimmune 
disease, whereas the response in other strains is confined to determinants specific for 
chick type II collagen. Thirdly,  it  may be that  the immune response to collagen  is 
against a common antigen determinant in all mouse strains, whereas the response of 
I q haplotype  mice  is  higher  than  other  strains.  A  more  aggressive response  by  I q 
haplotype mice might result in damage to the joint cartilage and lead to inflammation 
and arthritis.  However, high  antibody responses were observed in  three strains not 
expressing I q. The level of antibody in B 10.D2  (H-2  a) was equivalent or higher than 
that  observed  in  all  the  arthritis-susceptible  (I  q)  strains.  Thus,  antibody  titer  as 
measured by RIA is not an accurate prediction  for the onset of arthritis.  Similarly, 
the antibody responses within  a  susceptible strain were not  indicative of the devel- 
opment of the disease. Arthritic mice overall showed a  tendency to produce higher 
anticollagen  antibody  titers  than  nonarthritic  mice,  but  arthritis  was  observed  in 
animals with  low antibody titers, particularly  in  B10.G mice.  Studies  to determine 
the role of the cellular response to type II collagen in arthritis and its relationship to 
disease susceptibility are being conducted at present. 
The  relationship  of type  II  collagen  arthritis  in  mice  to  RA  would  be  worth 
exploring.  The  histological  data  in  particular  indicate  that  the  features  observed 
within  the joint  correspond to the histological appearance of RA.  It is particularly 
relevant to examine any relationship that the H-2  q antigens of mice may have to the 
expression of HLA-DRw4  in  man,  either  in  structural  similarity or linkage  to  the 
control of immune responses. It is known that  70% of RA patients have circulating 
antibodies  to type II collagen  (5), and recent work by Solinger and colleagues  (19) 
indicates that individuals with HLA-DRw4 have an abnormal leukocyte response to 
collagen. 
Type II collagen  arthritis  in  mice may prove a  valuable model  for the  study of 
histocompatibility-linked arthritis in man. 
Summary 
A model of arthritis was established by the injection of type II collagen into mice. 
Only mice bearing the H-2  q haplotype were susceptible to the disease. Susceptibility 
was further mapped by the use of recombinant strains to the I q locus. Type II collagen 
arthritis was observed in the (resistant ×  susceptible)Fx cross. 
Mice strains were designated high, intermediate, or low responders with respect to 
the anti-type II antibody levels measured by radioimmunoassay. Arthritis-susceptible 
strains were all classified as high antibody responders. 
The clinical and histological appearance of type II collagen arthritis in the mouse 
indicates  that  it  may  be  a  good  animal  model  for  the  investigation  of  various 
immunogenetic traits in rheumatoid arthritis. 
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technical assistance,  and Mary Steege for preparation of the manuscript. 
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